Protalix BioTherapeutics (PLX) Shares Outstanding (2016 - 2024)
Historic Shares Outstanding for Protalix BioTherapeutics (PLX) over the last 16 years, with Q3 2024 value amounting to $73.6 million.
- Protalix BioTherapeutics' Shares Outstanding rose 93.41% to $73.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $73.6 million, marking a year-over-year increase of 93.41%. This contributed to the annual value of $73.0 million for FY2023, which is 3562.35% up from last year.
- Protalix BioTherapeutics' Shares Outstanding amounted to $73.6 million in Q3 2024, which was up 93.41% from $73.3 million recorded in Q2 2024.
- In the past 5 years, Protalix BioTherapeutics' Shares Outstanding registered a high of $73.6 million during Q3 2024, and its lowest value of $32.4 million during Q1 2020.
- For the 5-year period, Protalix BioTherapeutics' Shares Outstanding averaged around $53.3 million, with its median value being $48.7 million (2022).
- In the last 5 years, Protalix BioTherapeutics' Shares Outstanding surged by 13429.56% in 2020 and then surged by 93.41% in 2024.
- Quarter analysis of 5 years shows Protalix BioTherapeutics' Shares Outstanding stood at $34.8 million in 2020, then soared by 31.04% to $45.6 million in 2021, then rose by 18.07% to $53.8 million in 2022, then soared by 35.62% to $73.0 million in 2023, then increased by 0.93% to $73.6 million in 2024.
- Its Shares Outstanding was $73.6 million in Q3 2024, compared to $73.3 million in Q2 2024 and $73.1 million in Q1 2024.